Home > Insider Trading > Filing (0001562180-20-005989)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1253176	Vapotherm Inc	VAPO	Surgical & Medical Instruments & Apparatus (3841)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1752566	David Blouin	100 Domain Drive Exeter NH 03833	Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-09-14	2,500	$1.68	37,090	No	4	M	Direct
Common Stock	Disposition	2020-09-14	2,500	$27.63	34,590	No	4	S	Direct
Common Stock	Disposition	2020-09-14	2,500	$27.47	32,090	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Option to purchase Common Stock	Disposition	2020-09-14	2,500	$0.00	2,500	$1.68

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
29,940		2028-01-17	No	4	M	Direct

Footnotes

The reported ownership includes 2,150 shares acquired under the Issuer's Employee Stock Purchase Plan on May 14, 2020.
This transaction was executed in multiple trades at prices ranging from $27.60 to $27.67. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $27.441 to $27.49. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This option vested 25% of the underlying shares on January 17, 2019 and thereafter, as to the remaining 75% of underlying shares, has been and will continue to vest in 36 monthly installments, provided that the Reporting Person continues to serve as an employee to the Issuer on each vesting date and otherwise subject to the Company's applicable equity incentive plan.